You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nasopharyngeal Carcinoma

Showing 1 - 25 of 8,214
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nasopharyngeal Carcinoma Trial in Wuhan (KSD-101)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • KSD-101
  • Wuhan, China
    Tongji Hospital, Tongji Medical College, Huazhong University of
Oct 19, 2023

Nasopharyngeal Carcinoma Trial in Hangzhou (Endostar and Envafolimab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Endostar and Envafolimab
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 24, 2023

Nasopharyngeal Carcinoma by AJCC V8 Stage Trial (New-mode reduce-volume target IMRT)

Not yet recruiting
  • Nasopharyngeal Carcinoma by AJCC V8 Stage
  • New-mode reduce-volume target IMRT
  • (no location specified)
Oct 18, 2023

Nasopharyngeal Carcinoma Screening Based on Tongue Imaging

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Tongue image
  • Zhuhai, China
    The Fifth Affiliated Hospital of Sun Yat sen University
Nov 10, 2023

Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity

Not yet recruiting
  • Nasopharyngeal Carcinoma
    • Fuzhou, Fujian, China
      Department of radiation oncology, Fujian cancer hospital
    Nov 16, 2023

    Nasopharyngeal Carcinoma Trial in Hangzhou (Toripalimab)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Apr 2, 2023

    Spatial Transcriptomics of Stage IVa Nasopharyngeal Carcinoma

    Not yet recruiting
    • Stage IVA Nasopharyngeal Carcinoma
    • Intensity modulated radiation therapy (IMRT) combined with chemotherapy
    • Nanjing, China
      Jiangsu Cancer Hospital
    Jun 21, 2023

    Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitors Trial (Cadonilimab, Gemcitabine, Cisplatin)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • Immune Checkpoint Inhibitors
    • (no location specified)
    Jun 1, 2023

    Nasopharyngeal Carcinoma, Iron-deficiency, Anemia Trial in Guangzhou (Iron Isomaltoside 1000, Polysaccharide Iron Complex Pill,

    Recruiting
    • Nasopharyngeal Carcinoma
    • +2 more
    • Iron Isomaltoside 1000
    • +2 more
    • Guangzhou, Guangdong, China
      Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
    Jun 19, 2023

    Nasopharyngeal Carcinoma Trial in Zhongshan (participants will undergo dual-energy CT and endoscopy)

    Recruiting
    • Nasopharyngeal Carcinoma
    • participants will undergo dual-energy CT and endoscopy
    • Zhongshan, Guangdong, China
      Zhongshan People's Hospital
    May 22, 2023

    Nasopharyngeal Carcinoma Trial in Zhongshan (Anrotinib plus Tirelizumab)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Anrotinib plus Tirelizumab
    • Zhongshan, Guangdong, China
      Zhongshan City People's Hospital
    Jul 31, 2023

    Predict Severe Oral Mucositis Associated With Chemoradiotherapy

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • Oral Mucositis
    • observational group
    • (no location specified)
    Sep 11, 2023

    Nasopharyngeal Carcinoma Trial in Wuhan (Cadonilimab)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Wuhan, Hubei, China
      Union Hospital, Tongji Medical College, Huazhong University of S
    Mar 27, 2023

    Nasopharyngeal Carcinoma, Intensity-Modulated Radiotherapy Trial in Zhongshan (Reduction CTVp1, Non-reduction CTVp1)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Intensity-Modulated Radiotherapy
    • Reduction CTVp1
    • Non-reduction CTVp1
    • Zhongshan, Guangdong, China
      Zhongshan City People's Hospital
    Aug 8, 2023

    Nasopharyngeal Carcinoma Trial in Guangzhou (Camrelizumab, Gemcitabine, Cisplatin)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Guangzhou, Guangdong, China
      Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
    May 3, 2023

    Acute Radiation Induced Oral Mucositis in Nasopharyngeal

    Recruiting
    • Nasopharyngeal Carcinoma by AJCC V8 Stage
    • Routine oral care
    • Guangzhou, Guangdong, China
      Yu Zeng
    May 16, 2023

    Nasopharyngeal Carcinoma Trial in Guangzhou (mobile platform or not mobile platform)

    Recruiting
    • Nasopharyngeal Carcinoma
    • mobile platform or not mobile platform
    • Guangzhou, Guangdong, China
      Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
    Apr 17, 2023

    Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8 Trial

    Not yet recruiting
    • Metastatic Nasopharyngeal Carcinoma
    • +2 more
    • Nivolumab
    • +5 more
    • (no location specified)
    Aug 21, 2023

    Nasopharyngeal Carcinoma Trial in Singapore (CCRT with Maintenance Tislelizumab and Metronomic Capecitabine)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • CCRT with Maintenance Tislelizumab and Metronomic Capecitabine
    • Singapore, Singapore
    • +1 more
    Oct 16, 2023

    Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • without concurrent cisplatin chemotherapy
    • with concurrent cisplatin chemotherapy
    • Fuzhou, Fujian, China
      Department of radiation oncology, Fujian cancer hospital
    Oct 18, 2023

    Nasopharyngeal Carcinoma Trial (Envafolimab and recombinant human endostatin combined with chemoradiotherapy)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • Envafolimab and recombinant human endostatin combined with chemoradiotherapy
    • (no location specified)
    Sep 23, 2023

    Nasopharyngeal Carcinoma Trial in Guangzhou, Zhongshan, Nanning (IMRT and concurrent cisplatin, gemcitabine and cisplatin

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • IMRT and concurrent cisplatin
    • gemcitabine and cisplatin (Induction chemotherapy)
    • Guangzhou, Guangdong, China
    • +3 more
    Jul 30, 2023

    Swallowing-induced Pain Trial in Guangzhou (doxepin solution, Placebo)

    Not yet recruiting
    • Swallowing-induced Pain
    • doxepin solution
    • Placebo
    • Guangzhou, Guangdong, China
      Southern medical university
    Aug 24, 2023

    Locally Advanced Nasopharyngeal Carcinoma Trial in Guangzhou (2 cycles induction chemo, 3 cycles induction chemo)

    Recruiting
    • Locally Advanced Nasopharyngeal Carcinoma
    • 2 cycles induction chemotherapy
    • 3 cycles induction chemotherapy
    • Guangzhou, Other (Non U.s.), China
      First Affiliated Hospital, Sun Yat-Sen University
    May 6, 2023

    Nasopharyngeal Carcinoma Trial in Beijing (Donafenib)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Beijing, Beijing, China
      Cancer Hospital of Medical College
    Nov 28, 2022